$3m CRC-P Grant Executed & First Payment Received
Filed with ASX · · 3 pages · English
Summary by 6ix AI
EMvision Medical Devices Ltd. has executed a grant agreement with the Australian government and received the first payment for a regional benefits study. The grant will support a collaboration aimed at improving stroke diagnosis and management in regional emergency departments. The study will utilize EMvision's emu™ brain scanner to demonstrate its clinical utility and improve patient outcomes. Planning for the clinical benefit study is currently underway, with candidate sites being reviewed for selection.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EMvision Medical Devices Ltd. on 6ix
Story so far
Earlier from EMvision Medical Devices
- SPP Offer Document & Option Prospectus
- Pre-Hospital MSU Study Commences with First Responder Device
- Firm Commitments for $12.0M Placement & Launch of SPP
- Trading Halt
- Appendix 4E & Annual Report to 30 June 2025
Later from EMvision Medical Devices
- Oversubscribed SPP To Close Early
- Oversubscribed SPP Raises $2.0M
- First Responder Aeromedical Study Commences
- Strong emu Clinical Trial & Program Progress
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices